EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Why cost-effectiveness thresholds for global health donors should differ from thresholds for Ministries of Health (and why it matters)

Tom Drake iD, Y-Ling Chi, Alec Morton iD, Catherine Pitt iD

F1000Research · 18.01.2024 · 12 · 214

DOI: 10.12688/f1000research.131230.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 18.01.2024. Verfasst von Tom Drake und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health, Centre for Global Development, London, UK. Hauptthemen laut MEDLINE: Cost-Effectiveness Analysis, Global Health. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Healthcare cost-effectiveness analysis is increasingly used to inform priority-setting in low- and middle-income countries and by global health donors. As part of such analyses, cost-effectiveness thresholds are commonly used to determine what is, or is not, cost-effective. Recent years have seen a shift in best practice from a rule-of-thumb 1x or 3x per capita GDP threshold towards using thresholds that, in theory, reflect the opportunity cost of new investments within a given country. In this paper, we observe that international donors face both different resource constraints and opportunity costs compared to national decision-makers. Hence, their perspective on cost-effectiveness thresholds must be different. We discuss the potential implications of distinguishing between national and donor thresholds and outline broad options for how to approach setting a donor-perspective threshold. Further work is needed to clarify healthcare cost-effectiveness threshold theory in the context of international aid and to develop practical policy frameworks for implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Effectiveness AnalysisGlobal HealthCost-Benefit AnalysisHeadPolicy

Stichwörter der Autor:innen

Global healthaidcost-effectivenesshealth financingpriority-settingthreshold

Autor:innen und Institutionen

  • Department of Global Health, Centre for Global Development, London, UK.
  • Strathclyde Business School, University of Strathclyde, Strathclyde, UK.
  • Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.

ORCID-Profile: Tom Drake, Alec Morton, Catherine Pitt

Förderung

  • Bill and Melinda Gates Foundation

Zitieren

APA

Drake, T., Chi, Y. L., Morton, A., & Pitt, C. (2024). Why cost-effectiveness thresholds for global health donors should differ from thresholds for Ministries of Health (and why it matters). F1000Research, 12, 214. https://doi.org/10.12688/f1000research.131230.2

Vancouver

Drake T, Chi YL, Morton A, Pitt C. Why cost-effectiveness thresholds for global health donors should differ from thresholds for Ministries of Health (and why it matters). F1000Research. 2024;12:214. doi:10.12688/f1000research.131230.2

BibTeX
@article{Drake2024,
  author = {Drake, Tom and Chi, Y-Ling and Morton, Alec and Pitt, Catherine},
  title = {Why cost-effectiveness thresholds for global health donors should differ from thresholds for Ministries of Health (and why it matters)},
  journal = {F1000Research},
  year = {2024},
  volume = {12},
  pages = {214},
  doi = {10.12688/f1000research.131230.2}
}
Kostenlos starten →